Landscapes / Companies
Rise Therapeutics LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
7 active
8 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 30 Nov 2026soonPhase 1 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Arthritis, Rheumatoid, Sjogren's Syndrome and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2028Phase 1 trial completes | |||
| Next date | 30 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | 15 Mar 2029Phase 1 trial completes | |||
| Next date | 15 Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Adult, Solid Tumor and 4 more | ||||
| Open drug page | |||||
About
- No active trial
- R-5280
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021